Expect Equity LLC bought a new position in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 170,666 shares of the company's stock, valued at approximately $1,369,000. Expect Equity LLC owned about 0.44% of Viemed Healthcare at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Divisadero Street Capital Management LP increased its stake in Viemed Healthcare by 84.8% in the 4th quarter. Divisadero Street Capital Management LP now owns 646,273 shares of the company's stock valued at $5,183,000 after buying an additional 296,481 shares during the last quarter. Renaissance Technologies LLC increased its stake in Viemed Healthcare by 2.3% in the 4th quarter. Renaissance Technologies LLC now owns 373,000 shares of the company's stock valued at $2,991,000 after buying an additional 8,400 shares during the last quarter. Bard Associates Inc. increased its stake in Viemed Healthcare by 1.3% in the 4th quarter. Bard Associates Inc. now owns 349,526 shares of the company's stock valued at $2,803,000 after buying an additional 4,474 shares during the last quarter. First Eagle Investment Management LLC increased its stake in Viemed Healthcare by 196.5% in the 4th quarter. First Eagle Investment Management LLC now owns 328,824 shares of the company's stock valued at $2,637,000 after buying an additional 217,923 shares during the last quarter. Finally, Northern Trust Corp increased its stake in Viemed Healthcare by 1.8% in the 4th quarter. Northern Trust Corp now owns 286,818 shares of the company's stock valued at $2,300,000 after buying an additional 5,090 shares during the last quarter. Institutional investors and hedge funds own 74.24% of the company's stock.
Viemed Healthcare Stock Down 0.4%
NASDAQ:VMD traded down $0.03 on Wednesday, hitting $6.86. The stock had a trading volume of 128,495 shares, compared to its average volume of 142,288. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. The stock has a market cap of $271.13 million, a P/E ratio of 25.41 and a beta of 1.49. Viemed Healthcare, Inc. has a 1 year low of $6.14 and a 1 year high of $9.81. The firm's fifty day simple moving average is $7.05 and its two-hundred day simple moving average is $7.89.
Viemed Healthcare (NASDAQ:VMD - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.06 EPS for the quarter, meeting the consensus estimate of $0.06. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%. The firm had revenue of $59.10 million during the quarter, compared to analyst estimates of $60.60 million.
About Viemed Healthcare
(
Free Report)
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Featured Stories

Before you consider Viemed Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.
While Viemed Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.